The Regionalization of High‐Volume Cardiac Pacing: A Prospective Cohort Study on Safety, Feasibility, and the Learning Curve in a Geriatric Population
Clinical Cardiology · 2026-10 · 49 (10)
DOI: 10.1002/clc.70479 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Cardiology, online erschienen am 29.09.2026. Verfasst von Sergejs Pikta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Internal Medicine, Daugavpils Regional Hospital, Daugavpils, Latvia. Hauptthemen laut MEDLINE: Learning Curve, Cardiac Pacing, Artificial, Hospitals, High-Volume, Pacemaker, Artificial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Centralizing pacemaker implantations delays care for geriatric populations in remote regions, particularly in post‐Soviet healthcare systems like Latvia. We hypothesized that a regional hospital could safely establish a high‐volume pacing program to overcome geographical barriers, utilizing structured mentorship from a national tertiary center.
Methods
This 2‐year prospective observational study evaluated 173 consecutive patients (mean age 78.1 years) undergoing permanent pacemaker implantation at Daugavpils Regional Hospital. Procedures were performed by two regional interventional cardiologists transitioning to independent practice, supported by Latvian Cardiology Centre mentors. Endpoints included 30‐day major complications, procedural efficiency, surgical learning curve evaluation using Cumulative Sum (CUSUM) analysis, and patient‐reported quality of life (AQUAREL, SF‐36).
Results
Across 173 procedures (66.5% dual‐chamber, 33.5% single‐chamber), the overall complication rate was 5.7%. CUSUM analysis demonstrated a complication rate reduction from 8.7% during the initial acquisition phase to a 3.4% expertise plateau. Procedural efficiency stabilized with a mean fluoroscopy time of 3.9 min. Specific complications included lead dislodgement (2.3%), pocket hematoma (1.7%), pneumothorax (1.1%), and wound infection (0.6%), managed successfully without mortality or device abandonment. At 6‐month follow‐up, patients reported significant quality of life improvements and high trust in the regional team.
Conclusions
Regional high‐volume cardiac pacing programs are safe and vital for equitable geriatric care. With structured mentorship, regional hospitals can overcome historical centralization, safely transitioning to independent high‐volume centers and achieving an expert‐level safety profile non‐inferior to tertiary standards.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Internal Medicine, Daugavpils Regional Hospital, Daugavpils, Latvia.
- Medical Faculty, Riga Stradins University, Riga, Latvia.
- Latvian Cardiology Centre, Pauls Stradins Clinical University Hospital, Riga, Latvia.
- Faculty of Medicine, University of Latvia, Riga, Latvia.
ORCID-Profile: Sergejs Pikta, Deniss Vasiļjevs, Oskars Kalejs
Zitieren
APA
Pikta, S., Vasiļjevs, D., Kupics, K., Kalejs, O., & Nesterovics, N. (2026). The Regionalization of High‐Volume Cardiac Pacing: A Prospective Cohort Study on Safety, Feasibility, and the Learning Curve in a Geriatric Population. Clinical Cardiology, 49(10). https://doi.org/10.1002/clc.70479
Vancouver
Pikta S, Vasiļjevs D, Kupics K, Kalejs O, Nesterovics N. The Regionalization of High‐Volume Cardiac Pacing: A Prospective Cohort Study on Safety, Feasibility, and the Learning Curve in a Geriatric Population. Clinical Cardiology. 2026;49(10). doi:10.1002/clc.70479
BibTeX
@article{Pikta2026,
author = {Pikta, Sergejs and Vasiļjevs, Deniss and Kupics, Kaspars and Kalejs, Oskars and Nesterovics, Nikolajs},
title = {The Regionalization of High‐Volume Cardiac Pacing: A Prospective Cohort Study on Safety, Feasibility, and the Learning Curve in a Geriatric Population},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {10},
doi = {10.1002/clc.70479}
}
EUVIMED